News Article

As fans of numerous science fiction series know (Matrix, Terminator, et al. we are looking at you), before too long our future robot overloads may be plotting our demise.
 
In the meantime, however, they are proving to be incredibly helpful in areas like pharma manufacturing, attracting billions in investment and kickstarting a robotic revolution.
 
This month in the PharmaTimes, Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor look at recent developments, and consider the benefits to efficiency, quality, and speed, and a thorny question: To what extent the word is ready to hand over the manufacturing reigns to increasingly autonomous robots?